Solazyme Bunge Renewable Oils Plant Begins Commercial Production in Brazil

  Solazyme Bunge Renewable Oils Plant Begins Commercial Production in Brazil

Business Wire

SOUTH SAN FRANCISCO, Calif. -- May 29, 2014

Solazyme, Inc. (NASDAQ: SZYM) (“Solazyme”), a renewable oil and bioproducts
company, today announced that its joint venture with Bunge Global Innovation
LLC (“Bunge”), a wholly-owned subsidiary of Bunge Limited (NYSE:BG), has
successfully produced its first commercially saleable products on full-scale
production lines, including the 625,000L fermentation tanks, at the Solazyme
Bunge Renewable Oils plant in Brazil. Both oil and encapsulated lubricant,
Encapso™, products have been manufactured; production is continuing and is
expected to reach nameplate capacity within the next 12-18 months.

“With production underway at the Solazyme Bunge Renewable Oils plant, Solazyme
is manufacturing products at three large scale facilities, including our 2,000
MT/year integrated facility in Peoria, the 20,000 MT/year Iowa facilities in
Clinton/Galva and the 100,000 MT/year facility in Brazil,” said Jonathan
Wolfson, CEO Solazyme. “Continued progress at the recently completed adjoining
co-gen facility has resulted in more reliable power and steam, enabling
startup of commercial operations and production of our first commercially
saleable product. We are truly excited to have begun manufacturing operations
at our joint venture’s flagship facility in Brazil.”

"The start of production at the Solazyme Bunge Renewable Oils plant is an
important milestone for this joint venture. We’re proud of the work we have
done with our partner Solazyme in bringing the world's first built-for-purpose
renewable oil plant on line. We remain committed to the success of the joint
venture and see significant market opportunities that we can address
together," said Ben Pearcy, Managing Director, Sugar & Bioenergy, Bunge

About Solazyme, Inc.

Solazyme, Inc. (SZYM) is a renewable oil and bioproducts company that
transforms a range of low-cost, plant-based sugars into high-value oils.
Headquartered in South San Francisco, Solazyme’s renewable products can
replace or enhance oils derived from the world’s three existing sources –
petroleum, plants and animal fats. Initially, Solazyme is focused on
commercializing its products into four target markets: (1) fuels and
chemicals, (2) nutrition, (3) encapsulated lubricants and (4) consumer

Solazyme®, Encapso™, and the Solazyme logo are trademarks of Solazyme, Inc.

Forward Looking Statements

This press release contains certain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 about
Solazyme, including statements that involve risks and uncertainties
concerning: its commercialization and production plans; the expected nameplate
capacity of its facilities and the timing of the ramp up of its facilities.
When used in this press release, the words “will”, “expects”, “intends” and
other similar expressions and any other statements that are not historical
facts are intended to identify those assertions as forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
Any such statement may be influenced by a variety of factors, many of which
are beyond the control of Solazyme, that could cause actual outcomes and
results to be materially different from those projected, described, expressed
or implied in this press release due to a number of risks and uncertainties.
Potential risks and uncertainties include, among others: Solazyme’s limited
operating history; implementation risk in deploying new technologies; its
limited experience in constructing, ramping up and operating commercial
manufacturing facilities; the availability of consistent, reliable power and
steam; its ability to enter into and maintain strategic collaborations; its
ability to obtain requisite regulatory approvals; and its access, on favorable
terms, to any required financing. Accordingly, no assurances can be given that
any of the events anticipated by the forward-looking statements will transpire
or occur, or if any of them do so, what impact they will have on the results
of operations or financial condition of Solazyme.

In addition, please refer to the documents that Solazyme, Inc. files with the
Securities and Exchange Commission, including its Quarterly Reports on Form
10-Q, as updated from time to time, for a discussion of these and other risks.
You are cautioned not to place undue reliance on forward-looking statements,
which speak only as of the date of this press release. Solazyme is not under
any duty to update any of the information in this press release.


Solazyme, Inc.
Genet Garamendi, 650-780-4777
VP Corporate Communications
Press spacebar to pause and continue. Press esc to stop.